Lakefront Biotherapeutics (LKFT) Enterprise Value (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported Enterprise Value of -$3.5 billion for Q1 2026, down 2.74% year-over-year from -$3.6 billion in Q1 2025, and down 0.75% quarter-over-quarter from -$3.5 billion in Q4 2025.
Lakefront Biotherapeutics (LKFT) Enterprise Value (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of Enterprise Value data on file, last reported at -$3.5 billion in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$3.5 billion, down 2.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.5 billion (down 2.74% YoY), and the FY2025 annual result was -$3.5 billion, down 4.76% from the prior year.
- Enterprise Value slipped to -$3.5 billion in Q1 2026 per LKFT's latest filing, from -$3.5 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$179.6 million in Q2 2024 and troughed at -$6.3 billion in Q1 2022.
- A 5-year average of -$3.6 billion and a median of -$3.6 billion in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value climbed 25.6% in 2023, then tumbled 1843.4% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$4.2 billion in 2022, then climbed by 5.09% to -$4.0 billion in 2023, then advanced by 15.96% to -$3.3 billion in 2024, then fell by 4.76% to -$3.5 billion in 2025, then slipped by 0.75% to -$3.5 billion in 2026.
- Business Quant data shows LKFT's Enterprise Value at -$3.5 billion in Q1 2026, -$3.5 billion in Q4 2025, and -$3.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | -3.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.52 Bn |
| Dec 31, 2025 | -3.49 Bn |
| Sep 30, 2025 | -3.57 Bn |
| Jun 30, 2025 | -3.49 Bn |
| Mar 31, 2025 | -3.42 Bn |
| Dec 31, 2024 | -3.33 Bn |
| Sep 30, 2024 | -3.79 Bn |
| Jun 30, 2024 | -179.64 Mn |
| Mar 31, 2024 | -3.97 Bn |
| Dec 31, 2023 | -3.96 Bn |
| Sep 30, 2023 | -4.53 Bn |
| Mar 31, 2023 | -4.69 Bn |
| Dec 31, 2022 | -4.18 Bn |
| Sep 30, 2022 | -2.25 Bn |
| Mar 31, 2022 | -6.31 Bn |
| Dec 31, 2021 | -5.38 Bn |
| Jun 30, 2021 | -6.03 Bn |
| Mar 31, 2021 | -3.08 Bn |
| Dec 31, 2020 | -6.15 Bn |
| Jun 30, 2020 | -5.56 Bn |